Corbus Pharmaceuticals Announces Completion of Enrollment in NIH-Sponsored Phase 2 Study of Lenabasum for Treatment of Systemic Lupus Erythematosus (SLE)
April 20, 2021 08:05 ET
|
Corbus Pharmaceuticals Holdings, Inc.
First study to explore potential benefit of a cannabinoid receptor type 2 agonist in SLEStudy sponsored and funded by the National Institute of Allergy and Infectious Diseases through the Autoimmunity...
Corbus Pharmaceuticals Announces Corporate Restructuring and Pipeline Portfolio Updates
October 08, 2020 08:05 ET
|
Corbus Pharmaceuticals Holdings, Inc.
Company is restructuring with the goal of extending cash runway to mid-2022Workforce to be reduced by 54%Company to focus on completing Phase 3 dermatomyositis study and advancing preclinical pipeline...
Global Systemic Lupus Erythematosus Market – Estimated to Gain Traction with Arrival of Key Pipeline Agents, with Promising Higher Efficacy than Existent Therapies - PMI
August 20, 2020 10:35 ET
|
PMI
Covina, CA, Aug. 20, 2020 (GLOBE NEWSWIRE) -- The report "Global Systemic Lupus Erythematosus Market, By Drug Classes (NSAIDs, Corticosteroids, Antimalarials, Immunosuppressants, and Biologics),...
Systemic Lupus Erythematosus Market Size Worth Around USD 2.7 billion by 2026: Acumen Research and Consulting
February 21, 2019 11:00 ET
|
Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Systemic Lupus Erythematosus Market (By Drug Classes: NSAIDs, Corticosteroids,...
Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in October
September 26, 2018 08:00 ET
|
Corbus Pharmaceuticals Holdings, Inc.
– Cantor Global Healthcare Conference presentation with live audio webcast on Monday, October 1st at 2:55 PM ET – – Leerink Partners Roundtable Series: Rare Disease & Oncology fireside chat...
Autoimmune Disease Diagnostics Market worth over $16 Billion by 2024: Global Market Insights, Inc.
October 19, 2017 07:00 ET
|
Global Market Insights, Inc
Ocean View, Delaware, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Autoimmune Disease Diagnostics Market is expected to cross USD 16 billion by 2024; according to a new research report by Global Market...
Benlysta Shatters Market Expectations and Upholds Cutting Edge Information's Forecast
July 23, 2009 10:04 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - July 23, 2009) - Benlysta, an experimental
treatment for lupus, recently surprised many industry observers with
positive clinical news.
On Monday, shares...